semaglutide training for nurse practitioners and tirzepatide are both injectable medications used in medical weight management—but they act on different metabolic pathways, which is why patient selection matters. Semaglutide (GLP-1 receptor agonist): • Primarily targets appetite Semaglutide and Tirzepatide: Prescribing and

There are a few review papers out now that speak to their potential and how they need to be explored more for osteoarthritis, so I think it's definitely picking up

What is included matters as much as the number in our program price, which covers provider visits, dose adjustments and check-ins, not just the medication

Our goal is to provide medical guidance in a supportive environment where you feel informed, comfortable, and confident in your plan

Prescription Drug Management Updates: New step therapy requirements and Market Watch additions for select medications

Nov 17: AstraZeneca scored a first-in-class approval for its pan-AKT inhibitor capivasertib as a treatment for adults with hormone receptorpositive and HER2-negative locally advanced or metastatic breast cancer whose tumors also have PIK3CA, AKT1 or PTEN mutations

Other effects Other physical effects can occur after you stop taking GLP-1 medications, including: Metabolism may be lower after weight loss Any time we lose weight, with or without medication, the body burns fewer calories, said Ms